“This usability study is a key milestone in advancing NASARIX™ toward clinical trials, which are expected to commence in Q3 2026,” said Tomer Izraeli, CEO of Polyrizon. “It underscores our commitment ...

Polyrizon Ltd. ( (PLRZ) ) has provided an announcement.

While current clinical trials for cardiac regeneration using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) employ immunosuppressive regimens used in heart transplants, the precise ...

The requirement to manually perform regular checks and balances on enterprise procurement has often been viewed as slowing ...

Comparison of Passwordless Authentication and MFA for CTOs. Explore security, UX, and implementation strategies for ...

Looking for the best career opportunities in technology in Nigeria? Discover top tech careers, the courses to study, and where to work for a successful future.

At this year's conference, TransCelerate and representatives from its member companies, including Amgen, Merck, and Pfizer, will participate in seven sessions addressing topics such as data collection ...

Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no ...

OpenAI announced that ads will start testing on ChatGPT for logged in adults in the US on the Free and Go tiers. The company ...